Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hawaii Pacific Neuroscience (HPN) is the largest multidisciplinary neuroscience center in Hawaii, offering specialized clinical care and advanced research opportunities. The organization operates several dedicated centers of excellence, including the Alzheimer’s Disease & Memory Center and the Parkinson’s & Movement Disorders Center. HPN is notably active in clinical research, serving as a primary site for numerous Phase 1 through Phase 4 clinical trials for neurological disorders in the Pacific region. By integrating academic-level research with private practice, HPN provides patients with access to cutting-edge treatments and diagnostic tools that are often unavailable elsewhere in the state. The center also emphasizes education through its neuroscience fellowship programs and clinical rotations for medical students.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hawaii Pacific Neuroscience.